Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F18%3A50014456" target="_blank" >RIV/62690094:18450/18:50014456 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.3233/JAD-171028" target="_blank" >http://dx.doi.org/10.3233/JAD-171028</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3233/JAD-171028" target="_blank" >10.3233/JAD-171028</a>
Alternative languages
Result language
angličtina
Original language name
Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis
Original language description
Background: There is now a general attempt in developed countries to implement strategic plans to fight against Alzheimer's disease and other dementia disorders. Among others, attention is paid to the issues of registers and calculations of economic burden. Currently available calculations of costs are difficult to compare. The problem is a different breakdown of cost categories and non-unified monitoring of cost types. Objective: The aim of this paper is to note the problem of poor availability and inconsistencies in cost monitoring. Furthermore, the intersection of cost items that are comparable and consistently monitored in expert studies are specified. Methods: The Web of Science, Elsevier Science Direct, PubMed, and Scopus databases are used in a systematic review. Two independent reviewers screened the identified records and selected relevant articles published in the period from 2010 to 2016. A meta-analysis of costs is performed in four categories related to patients suffering from Alzheimer's disease. Results: The resulting estimation of total costs per patient per month through meta-analysis is (sic) 3,896, with 95% CI [2078, 5713]. The highest costs arise from informal care following non-medical and medical care. Conclusion: The results confirm assumption that inconsistencies in cost monitoring of the treatment and care of people with dementia exists in Europe. Homogeneity could be assumed only in the medical costs of severe patients. Heterogeneity is assumed in non-medical costs, informal costs. Cost items should be defined and collected more precisely for future more precise monitoring of the economic burden.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
50202 - Applied Economics, Econometrics
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Alzheimer’s disease
ISSN
1387-2877
e-ISSN
—
Volume of the periodical
63
Issue of the periodical within the volume
1
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
12
Pages from-to
227-238
UT code for WoS article
000430016100022
EID of the result in the Scopus database
2-s2.0-85060700118